Company Filing History:
Years Active: 2022-2025
Title: Luc Selig: Innovator in Skeletal Muscle Research
Introduction
Luc Selig is a notable inventor based in Charenton le Pont, France. He has made significant contributions to the field of skeletal muscle research, holding two patents that focus on enhancing muscle performance and regeneration. His work is pivotal in addressing muscle-related diseases and injuries.
Latest Patents
Luc Selig's latest patents include innovative compounds that serve as ALK5 inhibitors and LSD1 inhibitors. The first patent relates to ALK5 inhibitors as skeletal muscle hypertrophy inducers. This invention aims to promote skeletal muscle regeneration, prevent muscle atrophy, and treat conditions resulting in muscle tissue loss or weakness. Additionally, it discusses the non-therapeutic use of these compounds to enhance muscle mass, strength, and performance. The second patent focuses on LSD1 inhibitors, which share similar applications in promoting muscle hypertrophy and regeneration, as well as preventing muscle-related issues.
Career Highlights
Luc Selig is currently associated with Cytoo, a company that specializes in innovative solutions in the field of cell biology. His work at Cytoo has allowed him to explore and develop groundbreaking technologies that contribute to muscle health and performance.
Collaborations
Luc collaborates with talented individuals such as Pauline Poydenot and Joris Michaud. Their combined expertise fosters a productive environment for innovation and research.
Conclusion
Luc Selig's contributions to skeletal muscle research through his patents and work at Cytoo highlight his role as a significant inventor in this field. His innovations have the potential to greatly impact muscle health and performance.